Objective: To study the frequency of hypocalcemia in neonates receiving phototherapy with indirect hyperbilirubinemia Materials and Methods: Descriptive case series was conducted from September 5, 2018, to March 2019, NICU Paediatric Department Benazir Bhutto Hospital, Rawalpindi.
 Approval sought hospital’s ethical committee. Neonates fulfilling inclusion criteria were enrolled after obta...

Background Hyperbilirubinemia occurs in 60% of full term and 80% premature infants. Phototherapy is the main treatment, but it has side effects, sometimes requires hospitalization, causes baby to be separated from mother. Underdeveloped gut microflora increased enterohepatic circulation newborns contribute serum bilirubin levels early life.
 Objective To assess efficacy adding probiotic L....

Phototherapy was developed in the late 1950s and is today considered the mainstay of managing neonatal jaundice. Yet prominent academic leaders continued to promote the older approach of exchange transfusion well into the 1970s, despite the considerable risks involved. This article explores why phototherapy took so long to be embraced, and how pediatric residents were caught in the middle of th...

Phototherapy (UV-A and UV-B) has become one of the most commonly used modalities for the treatment of a variety of skin diseases, although the action mechanisms have not been fully understood. Inhibition of DNA synthesis by UV radiation may be one of the therapeutic effects in proliferating skin diseases; however, phototherapy is also used for the treatment of allergic or autoimmune diseases.

OBJECTIVE To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. METHODS Relevant literature was reviewed. Phototherapy devices currently marketed in the United States that incorporate fluorescent, halogen, fiber-optic, or blue light-emit...

High intensity light emitting diodes (LEDs) are being studied as possible light sources for the phototherapy of neonatal jaundice, as they can emit high intensity light of narrow wavelength band in the blue region of the visible light spectrum corresponding to the spectrum of maximal bilirubin absorption. We developed a prototype blue gallium nitride LED phototherapy unit with high intensity, a...

OBJECTIVE To assess the effect of phototherapy on serum oxidant and antioxidant status in hyperbilirubinemic full-term newborns. METHOD Thirty-four full-term infants from 3 to 10 days of age exposed to phototherapy were studied. The serum antioxidant status was assessed by measuring the total antioxidant capacity (TAC) and individual antioxidant components: vitamin C, uric acid, albumin, thio...

BACKGROUND Vitiligo is an acquired pigmentary cutaneous disease, characterised by the progressive loss of melanocytes, resulting in hypopigmented skin areas which progressively become amelanotic. Classically, vitiligo treatments are unsatisfactory and challenging. Despite the continuous introduction of new therapies, phototherapy is still the mainstay for vitiligo repigmentation. AIM The aim ...

BACKGROUND Previous studies have shown positive results of phototherapy for improving performance and accelerating recovery; however, the effects of phototherapy during training and after a primary adaptation remain unclear. The aim of this randomized controlled trial is to analyze the effects of phototherapy and combined training on clinical, functional, and psychological outcomes and on vascu...

exhibit two peaks; one at 265 nm, consistent with DNA absorption, and the second at 450 nm. Bilirubin absorbs maximally between 420 to 480 nm-the blue range. Despite such evidence, few clinically adverse side effects have been reported. Ennever et al3 found the most effective wavelength for the production of 4Z 15E bilirubin to be 390 nm with an overall effective band from 350 to 470 nm. But ot...